Early-Start Antiplatelet Treatment After Neurosurgery in Patients With Spontaneous Intracerebral Hemorrhage

• Status: Not yet recruiting
• Trial end date: 2023-05-01

Summary

This study is a multicenter, prospective, open-label, endpoint-blind, randomized controlled study.Patients receiving surgical treatment for SICH were divided into groups using the random machine method. In addition to conventional treatment for spontaneous intracerebral hemorrhage, patients in the group of early initiation of antiplatelet therapy were given conventional dose of aspirin (100mg, qd) antiplatelet therapy starting from the 3rd day after surgery.An independent group of investigators evaluated cardiac, cerebral and peripheral vascular events and bleeding events at four different time points.To evaluate the benefits and safety of early postoperative initiation of antiplatelet therapy in patients with spontaneous intracerebral hemorrhage.

• Phase: N/A

Details

• Lead Sponsor: Beijing Tiantan Hospital
• Collaborators: Beijing Chao Yang Hospital; Beijing Friendship Hospital; Binzhou Medical University; Chongqing General Hospital; First Affiliated Hospital of Fujian Medical University; First Affiliated Hospital of Harbin Medical University; Fujian Medical University Union Hospital; Gangzhou Red Cross Hospital ，Jinan University; Qilu Hospital of Shandong University; RenJi Hospital; Second Affiliated Hospital, School of Medicine, Zhejiang University; Shanxi Provincial People Hospital; Sichuan Academy of Medical Sciences; Sichuan Academy of Medical Sciences &Sichuan Provincial People's Hospital; The Second Affiliated Hospital of Kunming Medical University; The Second Xiangya Hospital of Central South Medical University
• Treatments: Platelet Aggregation Inhibitors